Skip to main content

Ophthalmology

0 drugs are in development for Retinitis Pigmentosa.

Companies
0
Clinical trials
13
BioSniper AIPage context preserved

Prepared research question

Which programs lead the Retinitis Pigmentosa pipeline—and what evidence could change the picture?

Run cited research

Traceable citations · Unknowns marked

About this indication

Retinitis Pigmentosa context

Ophthalmology·MeSH: Retinitis Pigmentosa (D012174)

Also known as: Pigmentary Retinopathies, Retinopathy, Pigmentary, Tapetoretinal Degeneration, Tapetoretinal Degenerations

Incidence

1.5 / 100K/yr